Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
P
1026
Everpure Inc
P
$36.4B
| $29.9M | 0.01% |
445,930
-39,529
| -8% | -$3.3M |
|
1027
UDR
UDR
$12B
| $29.9M | 0.01% |
814,648
-510,602
| -39% | -$18.2M |
|
1028
DraftKings
DKNG
$12.6B
| $29.9M | 0.01% |
866,961
-279,690
| -24% | -$9.2M |
|
1029
Burlington
BURL
$22.6B
| $29.8M | 0.01% |
103,258
-832,285
| -89% | -$226M |
|
1030
PUT
Roku
ROKU
$22.4B
| $29.6M | 0.01% |
272,900
-22,500
| -8% | -$2.28M |
|
1031
CALL
JD.com
JD
$43.1B
| $29.6M | 0.01% |
1,031,200
+628,300
| +156% | +$19.6M |
|
1032
CALL
Cummins
CMI
$87.1B
| $29.6M | 0.01% |
+57,900
| New | +$27.1M |
|
|
Q
1033
CALL
Qnity Electronics Inc
Q
$28.9B
| $29.5M | 0.01% |
+361,500
| New | +$30.7M |
|
1034
Wynn Resorts
WYNN
$10.8B
| $29.5M | 0.01% |
244,942
-262,003
| -52% | -$32.4M |
|
1035
Ovintiv
OVV
$17.6B
| $29.5M | 0.01% |
751,853
+274,361
| +57% | +$10.6M |
|
1036
Vertex
VERX
$1.98B
| $29.3M | 0.01% |
1,467,371
+624,147
| +74% | +$13.5M |
|
1037
CF Industries
CF
$17.8B
| $29.2M | 0.01% |
377,897
-127,722
| -25% | -$10.5M |
|
|
CMA
1038
DELISTED
Comerica
CMA
| $29.2M | 0.01% |
336,176
+140,254
| +72% | +$11.3M |
|
1039
DT Midstream
DTM
$13.7B
| $29.2M | 0.01% |
243,921
-46,718
| -16% | -$5.37M |
|
1040
Valley National Bancorp
VLY
$8.16B
| $29.1M | 0.01% |
2,494,461
+330,302
| +15% | +$3.66M |
|
1041
PUT
Affirm
AFRM
$25.7B
| $29.1M | 0.01% |
390,900
+270,000
| +223% | +$19.4M |
|
1042
PUT
Albemarle
ALB
$15.3B
| $29M | 0.01% |
205,000
-1,872,500
| -90% | -$213M |
|
1043
UFP Industries
UFPI
$5.12B
| $28.9M | 0.01% |
317,308
-39,937
| -11% | -$3.66M |
|
1044
Applied Digital
APLD
$8.55B
| $28.9M | 0.01% |
1,177,375
+793,113
| +206% | +$22.8M |
|
1045
CALL
Intercontinental Exchange
ICE
$84.9B
| $28.8M | 0.01% |
177,600
+42,000
| +31% | +$6.58M |
|
|
OKLO
1046
Oklo
OKLO
$8.74B
| $28.8M | 0.01% |
400,773
+239,278
| +148% | +$26.7M |
|
1047
iShares MSCI Brazil ETF
EWZ
$8.6B
| $28.7M | 0.01% |
904,741
-1,015,321
| -53% | -$32.1M |
|
1048
Hess Midstream
HESM
$5.2B
| $28.6M | 0.01% |
829,125
+93,065
| +13% | +$3.13M |
|
1049
Guidewire Software
GWRE
$14.7B
| $28.5M | 0.01% |
141,830
-7,775
| -5% | -$1.72M |
|
1050
Park Hotels & Resorts
PK
$2.89B
| $28.4M | 0.01% |
2,719,561
-323,269
| -11% | -$3.46M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.